Search
Find a company, briefing, or insight.
20 resultsfor "Healthcare"
Insights
Companies
RYM · Healthcare / Retirement living · 1 briefing
Ryman Healthcare
RYM's first positive FCF in a decade masks a $40.2m PBT loss
FPH · Healthcare / Medical devices · 6 briefings
Fisher & Paykel Healthcare
FPH NPAT up 39% but cash conversion fell sharply on profit outpacing OCF
OCA · Healthcare / Retirement living · 1 briefing
Oceania Healthcare
PBT scrapes to NZ$1.0m as tax benefit lifts NPAT and capex doubles
SUM · Healthcare / Retirement living · 2 briefings
Summerset Group Holdings
Underlying profit +13% but IFRS PBT collapsed 32% on fair-value swings
EBO · Healthcare / Healthcare distribution · 5 briefings
EBOS Group
EBOS HY26: NPAT up 13% but operating cash flow collapsed 76%
ARV · Healthcare / Retirement living · 1 briefing
Arvida Group
PBT swung to -$8.0m loss as fair-value gains evaporated on flat EBITDA
GXH · Healthcare / Pharmacy and health services · 7 briefings
GXH
GXH HY26: PBT up 13.7% as Medical lifts mix, but operating cash fell 14.6%
BLT · Healthcare / Biotechnology · 7 briefings
BLIS Technologies
BLIS revenue up 28% and NPAT up 83%, but OCF stuck at $0.006m
RAD · Healthcare / Aged care · 1 briefing
Radius Residential Care
Underlying EBITDA up 32% but FY23 swung to a $2.1m NPAT loss on property items
TAH · Healthcare / Primary healthcare · 2 briefings
Third Age Health Services
Acquisitions lifted revenue 61% but halved NPAT as integration costs bit
Briefings
RYM · HY26
RYM's first positive FCF in a decade masks a $40.2m PBT loss
Balance sheet reset is structurally positive, but operating earnings remain deeply negative while GAAP losses obscure the transformation narrative.
FPH · HY26
FPH NPAT up 39% but cash conversion fell sharply on profit outpacing OCF
Revenue grew 14% and margins expanded, yet operating cash flow rose only 5.5%, raising questions about earnings quality into the second half.
OCA · HY26
PBT scrapes to NZ$1.0m as tax benefit lifts NPAT and capex doubles
Headline swing to profit masks a barely-breakeven pre-tax result, an NZ$8.4m free cash outflow, and leverage still at 14.5x EBITDA.
FPH · FY25
NPAT up 50.7% and pre-lease FCF surged from $26.9m to $445.6m
Operating leverage on 27.8% revenue growth combined with a $108.3m capex step-down to deliver a cash-flow inflection and a clear net-cash position.
FPH · HY25
FPH HY25: NPAT up 43% as free cash flow swings to +$169.4m
Revenue growth of 18.4% converted to a net cash balance sheet as capex normalised from $275.5m to $55.1m.
FPH · HY24
PBT up 23% but FCF swings to -NZ$127.5m as capex jumps to 34% of sales
Revenue momentum and a PBT recovery are offset by capex-led cash burn, doubled gross borrowings and a dividend no longer covered by free cash flow.
FPH · FY23
FPH FY23: PBT down 35% as pre-lease free cash flow collapsed to $26.9m
A 14% H2 revenue rebound partially masks a post-COVID reset in hospital hardware, a working-capital build, and capex that lifted to 13.4% of revenue.
FPH · HY23
PBT fell 62% as post-COVID revenue reset flipped FPH into a net debt position
Hospital revenue normalised, inventory days nearly doubled, operating cash fell to NZ$1.9m, yet the interim dividend still edged up.
EBO · HY25
EBOS HY25: statutory NPAT down 18.9% and leverage up to 3.86x as Healthcare...
Operating cash flow nearly doubled to NZ$189.8m, but the dividend now absorbs essentially all statutory earnings while net debt/EBITDA drifts higher.